Skip to content

Dr. Milo De Decker - Oftalmoloog

Active
Private limited companyfounded 2022active for 4 yearsKouterbaan 55, 1840 Londerzeel, BelgiumKBO/BCE: BE 0791.651.840
Summary

Dr. Milo De Decker - Oftalmoloog has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €457,161 and a net result of €391,747. Equity is growing by about 52% per year across the filed financial years. Its solvency ranks better than 29% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Dr. Milo De Decker - OftalmoloogActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
6th largest company by total assets in Londerzeel, Health and social work sector2 sites
Size
€1.3mtotal assets 2025
Equity
€457,161
Profit
€391,747
Turnover not published (abbreviated or micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 50 days early1 deed in the Belgian Official Gazette
Why 93lowers riskSector: Human health activities (NACE 86)Size: total assets €1.3mFigures for financial year 2025 (filed 11-06-2026)Liquidity: current ratio 1.83, cash €265,905Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 45% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 61-39
equity 35.9% of total assets
Liquidity 60-7
short-term debt 36.3% · cash 20.9%
Profitability 100=
return on assets 30.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026highest value 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.83, compared with 9.08 in 2024, above the usual 1.5; short-term debt: 36.3% and cash: 20.9% of total assets), but 64.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 30% on solvency, 37% on liquidity, 80% on profitability and 33% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.3m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 11-06-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.83, cash €265,905
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
50 days early
2024
37 days early
2023
57 days early
2022
77 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 55 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 June (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2022 to 2025net €391,747 ▲17.4%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 5% on net resultsector median €60,202 · 20,591 companies €391,747 View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View
  • Total assets 20254 financial years filed €1.3m View

By topic

Financials

Financial year
2025
Total assets
€1.3m
Profit
€391,747
Solvency
35.9%
Total assets▲ 144%
Net result
20222025
Go to Financials

Timeline

Events
7
Since
2023
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 04-06-2024Annual accounts filed
  3. 31-12-2023Equity above €100,000
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
30-09-2022
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Dr. Milo De Decker - Oftalmoloog

What is the company number of Dr. Milo De Decker - Oftalmoloog?
0791.651.840. In Belgium the VAT number is the company number with BE in front: BE 0791.651.840.
Where is Dr. Milo De Decker - Oftalmoloog based?
The registered office is at Kouterbaan 55, 1840 Londerzeel.Company details
What does Dr. Milo De Decker - Oftalmoloog do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Milo De Decker - Oftalmoloog?
Private limited company (BV).
When was Dr. Milo De Decker - Oftalmoloog founded?
On 30-09-2022.
Is Dr. Milo De Decker - Oftalmoloog still active?
Yes, Dr. Milo De Decker - Oftalmoloog is an active enterprise in the KBO register.
What is the turnover of Dr. Milo De Decker - Oftalmoloog?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. Milo De Decker - Oftalmoloog profitable?
In financial year 2025, Dr. Milo De Decker - Oftalmoloog made a profit of €391,747.
Where can I find the annual accounts of Dr. Milo De Decker - Oftalmoloog?
Dr. Milo De Decker - Oftalmoloog filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Milo De Decker - Oftalmoloog due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Dr. Milo De Decker - Oftalmoloog

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure